2012
DOI: 10.1016/j.nucmedbio.2012.06.003
|View full text |Cite
|
Sign up to set email alerts
|

18F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
30
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
3

Relationship

5
5

Authors

Journals

citations
Cited by 33 publications
(31 citation statements)
references
References 50 publications
1
30
0
Order By: Relevance
“…A similar trend was also observed by Burtea et al when the authors analyzed cell binding in apoptotic cells with Gd-DTPA-conjugated LIKKPF [10]. The observed substantial baseline uptake of both peptides ([ 18 F]FBAM-CLIKKPF and Gd-DTPA-g-LIKKPF) in untreated Jurkat cells could be explained by the lysine-rich and therefore basic and cationic nature of the LIKKPF peptide backbone, which may possess characteristics of a cellpenetrating peptide [19,20]. Taken together, results from our competitive radiometric PS-binding assay and data on cell binding in Jurkat cells (control and drug-treated) demonstrated that PS binding of both peptides LIKKPF and PGDLSR is several orders of magnitude lower compared to wild-type annexin V. Moreover, radiolabeled peptide [ 18 F]FBAM-CLIKKPF showed significantly higher uptake in drugtreated Jurkat cells, possibly as a result of specific interaction with elevated levels of PS as well as possible unspecific cell-penetrating peptide properties of the lysine-rich radiopeptide [ 18 F]FBAM-CLIKKPF.…”
Section: Discussionsupporting
confidence: 82%
“…A similar trend was also observed by Burtea et al when the authors analyzed cell binding in apoptotic cells with Gd-DTPA-conjugated LIKKPF [10]. The observed substantial baseline uptake of both peptides ([ 18 F]FBAM-CLIKKPF and Gd-DTPA-g-LIKKPF) in untreated Jurkat cells could be explained by the lysine-rich and therefore basic and cationic nature of the LIKKPF peptide backbone, which may possess characteristics of a cellpenetrating peptide [19,20]. Taken together, results from our competitive radiometric PS-binding assay and data on cell binding in Jurkat cells (control and drug-treated) demonstrated that PS binding of both peptides LIKKPF and PGDLSR is several orders of magnitude lower compared to wild-type annexin V. Moreover, radiolabeled peptide [ 18 F]FBAM-CLIKKPF showed significantly higher uptake in drugtreated Jurkat cells, possibly as a result of specific interaction with elevated levels of PS as well as possible unspecific cell-penetrating peptide properties of the lysine-rich radiopeptide [ 18 F]FBAM-CLIKKPF.…”
Section: Discussionsupporting
confidence: 82%
“…20 Furthermore, we used sC18 as an efficient delivery system for cytostatic drugs 21,22 as well as for imaging probes. 23,24 In all these studies sC18 itself behaved non-toxic to human cells, however, antimicrobial activity in the micromolar range against Escherichia coli and Micrococcus luteus has been observed. (unpublished results) The LL-37 peptide also belongs to the group of the cathelicidins and is a two amino acid truncated form of FALL-39, 25 which was identified as an antimicrobial peptide expressed in bone marrow.…”
Section: Introductionmentioning
confidence: 99%
“…An alternative route to radiolabel a peptide is through the use of a prosthetic group as an indirect radiolabeling method. [ 18 F]SFB [23] and even, the most abundantly used PET tracer, [ 18 F]FDG [24] have been utilized as prosthetic groups for the radiolabeling of peptides. Although both prosthetic groups were synthesized on macroscale equipment, the subsequent peptide radiolabeling was performed under microfluidic conditions.…”
Section: Early Work In This Area Featured the Direct [mentioning
confidence: 99%